MiR-30a increases MDSC differentiation and immunosuppressive function by targeting SOCS3 in mice with B-cell lymphoma

FEBS Journal

Volumn 284, Issue 15, 2017, Pages 2410-2424

  Xu, Zhen ^a   Ji, Jianjian ^a   Xu, Jingjing ^a   Li, Dan ^a   Shi, Guoping ^a   Liu, Fei ^a   Ding, Liang ^a   Ren, Jing ^a   Dou, Huan ^a   Wang, Tingting ^a   Hou, Yayi ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

B cell lymphoma; G MDSCs; M MDSCs; miR 30a; SOCS3

Indexed keywords

ARGINASE 1; GAMMA INTERFERON; INTERLEUKIN 10; JANUS KINASE 2; MARKER; MESSENGER RNA; MICRORNA; MICRORNA 30A; P47PHOX PROTEIN; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ARG1 PROTEIN, MOUSE; ARGINASE; MIRN30D MICRORNA, MOUSE; SOCS3 PROTEIN, MOUSE; TUMOR PROTEIN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; INTERFERON PRODUCTION; MOUSE; MYELOID-DERIVED SUPPRESSOR CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BONE MARROW CELL; CANCER TRANSPLANTATION; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; GRANULOCYTE PRECURSOR; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOMA, B-CELL; METABOLISM; MONOCYTE MACROPHAGE PRECURSOR CELL; PATHOLOGY; SPLEEN; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; ARGINASE; BONE MARROW CELLS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELLS, CULTURED; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOCYTE PRECURSOR CELLS; IMMUNOSUPPRESSION; LYMPHOMA, B-CELL; MICE; MICE, INBRED BALB C; MICRORNAS; MONOCYTE-MACROPHAGE PRECURSOR CELLS; MYELOID-DERIVED SUPPRESSOR CELLS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; SPLEEN; SUPPRESSOR OF CYTOKINE SIGNALING 3 PROTEIN; UP-REGULATION;

EID: 85026852738     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.14133     Document Type: Article

References (39)

1. Khanolkar RC, Kalogeropoulos M, Lawrie A, Roghanian A, Vickers MA & Young NT (2016) Leukocyte ig-like receptor b1 restrains dendritic cell function through increased expression of the nf-κb regulator abin1/tnip1. J Leukoc Biol 100, 4.
2. Reagan PM, Baran A, Kelly JL, Barr PM, Casulo C, Chengazi VU & Friedberg JW (2014) Consolidative radioimmunotherapy after chemoimmunotherapy in patients with histologic transformation of indolent Non-Hodgkin lymphoma. Meeting of the American-Society-Of-Hematology 16, 322–328.
3. Nyunt WW, Wong YP, Wan JW & Abdul Wahid SF (2016) Diffuse large b cell lymphoma with chronic granulomatous inflammation. Malays J Pathol 38, 55–59.
4. Ji D, Li Q, Cao J, Guo Y, Lv F, Liu X, Wang B, Wang L, Luo Z, Chang J et al. (2016) Thalidomide enhanced the efficacy of chop chemotherapy in the treatment of diffuse large b cell lymphoma: a phase ii study. Oncotarget 7, 33331.
5. Gomezgelvez JC, Salama ME, Perkins SL, Leavitt M & Inamdar KV (2016) Prognostic impact of tumor microenvironment in diffuse large b-cell lymphoma uniformly treated with r-chop chemotherapy. Am J Clin Pathol 145, 514.
6. Nael A, Walavalkar V, Wu W, Nael K, Kim R, Rezk S & Zhao X (2016) Cd4-positive t-cell primary central nervous system lymphoma in an hiv positive patient. Am J Clin Pathol 145, 258–265.
7. Marini O, Spina C, Mimiola E, Cassaro A, Malerba G, Todeschini G, Perbellini O, Scupoli M, Carli G, Facchinelli D et al. (2016) Identification of granulocytic myeloid-derived suppressor cells (g-mdscs) in the peripheral blood of hodgkin and non-hodgkin lymphoma patients. Oncotarget 7, 27676–27688.
8. Wu C, Wu X, Zhang X, Chai Y, Guo Q, Li L, Yue L, Bai J, Wang Z & Zhang L (2015) Prognostic significance of peripheral monocytic myeloid-derived suppressor cells and monocytes in patients newly diagnosed with diffuse large b-cell lymphoma. Int J Clin Exp Med 8, 15173–15181.
9. Yazdani Y, Mohammadnia-Afrouzi M, Yousefi M, Anvari E, Ghalamfarsa G, Hasannia H, Sadreddini S & Jadidi-Niaragh F (2015) Myeloid-derived suppressor cells in b cell malignancies. Tumor Biol 36, 7339–7353.
10. Serafini P, Mgebroff S, Noonan K & Borrello I (2008) Myeloid-derived suppressor cells promote cross-tolerance in b-cell lymphoma by expanding regulatory t cells. Can Res 68, 5439–5449.
11. Sato Y, Shimizu K, Shinga J, Hidaka M, Kawano F, Kakimi K, Yamasaki S, Asakura M & Fujii SI (2015) Characterization of the myeloid-derived suppressor cell subset regulated by nk cells in malignant lymphoma. Oncoimmunology 4, e995541.
12. Gabrilovich DI & Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9, 162–174.
13. Marvel D & Gabrilovich DI (2011) Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. J Clin Investigat 125, 3356–3364.
14. Ji J, Xu J, Zhao S, Liu F, Qi J, Song Y, Ren J, Wang T, Dou H & Hou Y (2016) Myeloid-derived suppressor cells contribute to systemic lupus erythaematosus by regulating differentiation of th17 cells and tregs. Clin Sci 130, 1453.
15. Azzaoui I, Uhel F, Rossille D, Pangault C, Dulong J, Le Priol J, Lamy T, Houot R, Le Gouill S, Cartron G et al. (2015) T-cell defect in diffuse large b-cell lymphomas involves expansion of myeloid-derived suppressor cells. Blood 128, 1081.
16. Tian J, Rui K, Tang X, Ma J, Wang Y, Tian X, Zhang Y, Xu H, Lu L & Wang S (2015) Microrna-9 regulates the differentiation and function of myeloid-derived suppressor cells via targeting runx1. J Immunol 195, 1301–1311.
17. Li L, Zhang J, Diao W, Wang D, Wei Y, Zhang CY & Zen K (2014) Microrna-155 and microrna-21 promote the expansion of functional myeloid-derived suppressor cells. J Immunol 192, 1034–1043.
18. Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, Kirak O, Brummelkamp TR, Fleming MD & Camargo FD (2008) Regulation of progenitor cell proliferation and granulocyte function by microrna-223. Nature 451, 1125–1129.
19. Liu Y, Lai L, Chen Q, Song Y, Xu S, Ma F, Wang X, Wang J, Yu H, Cao X et al. (2012) Microrna-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of pten. J Immunol 188, 5500–5510.
20. Kim S, Song JH, Kim S, Qu P, Martin BK, Sehareen WS, Haines DC, Lin PC, Sharan SK & Chang S (2016) Loss of oncogenic mir-155 in tumor cells promotes tumor growth by enhancing c/ebp-β-mediated mdsc infiltration. Oncotarget 7, 11094–11112.
21. Wang J, Yu F, Jia X, Iwanowycz S, Wang Y, Huang S, Ai W & Fan D (2015) Microrna-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth. Int J Cancer 136, 602–613.
22. Noman MZ, Janji B, Hu S, Wu JC, Martelli F, Bronte V & Chouaib S (2015) Tumor-promoting effects of myeloid-derived suppressor cells are potentiated by hypoxia-induced expression of mir-210. Can Res 75, 3771–3787.
23. Zhang R, Weng Y, Li B, Jiang Y, Yan S, He F, Chen X, Deng F, Wang J & Shi Q (2015) Bmp9-induced osteogenic differentiation is partially inhibited by mir-30a in the mesenchymal stem cell line c3h10t1/2. J Mol Histol 46, 399–407.
24. Tian Y, Guo R, Shi B, Chen L, Yang L & Fu Q (2016) Microrna-30a promotes chondrogenic differentiation of mesenchymal stem cells through inhibiting delta-like 4 expression. Life Sci 148, 220–228.
25. Rouzbeh S, Kobari L, Cambot M, Mazurier C, Hebert N, Faussat AM, Durand C, Douay L & Lapillonne H (2015) Molecular signature of erythroblast enucleation in human embryonic stem cells. Stem Cells 33, 2431–2441.
26. Hu E, Ding L, Miao H, Liu F, Liu D, Dou H & Hou Y (2015) Mir-30a attenuates immunosuppressive functions of il-1β-elicited mesenchymal stem cells via targeting tab3. FEBS Lett 589, 3899–3907.
27. Ortega M, Bhatnagar H, Lin AP, Wang L, Aster JC, Sill H & Aguiar RC (2014) A microrna-mediated regulatory loop modulates notch and myc oncogenic signals in b and T cell malignancies. Leukemia 29, 968–976.
28. Dias C & Isenberg DA (2011) Susceptibility of patients with rheumatic diseases to b-cell non-hodgkin lymphoma. Nat Rev Rheumatol 7, 360–368.
29. Yadlapati S & Efthimiou P (2016) Autoimmune/inflammatory arthritis associated lymphomas: who is at risk? Biomed Res Int 2016, 8631061.
30. Liu Y, Dong J, Mu R, Gao Y, Tan X, Li Y, Li Z & Yang G (2013) Microrna-30a promotes b cell hyperactivity in patients with systemic lupus erythematosus by direct interaction with lyn. Arthritis Rheumatol 65, 1603–1611.
31. Capello D, Gloghini A, Baldanzi G, Martini M, Deambrogi C, Lucioni M, Piranda D, Famà R, Graziani A, Spina M et al. (2013) Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-odgkin lymphoma. Hematol Oncol 31, 22–28.
32. Ruscica M, Ricci C, Macchi C, Magni P, Cristofani R, Liu J, Corsini A & Ferri N (2015) Suppressor of cytokine signaling-3 (socs-3) induces proprotein convertase subtilisin kexin type 9 (pcsk9) expression in hepatic hepg2 cell line. J Biol Chem 291, 3508–3519.
33. Huang L, Hu B, Ni J, Wu J, Jiang W, Chen C, Yang L, Zeng Y, Wan R, Hu G et al. (2016) Transcriptional repression of socs3 mediated by il-6/stat3 signaling via dnmt1 promotes pancreatic cancer growth and metastasis. J Exp Clin Cancer Res 35, 27.
34. Zhao LJ, He SF, Wang W, Ren H & Qi ZT (2016) Interferon alpha antagonizes stat3 and socs3 signaling triggered by hepatitis c virus. Cytokine 80, 48–55.
35. Chen S, Wang L, Fan J, Ye C, Dominguez D, Zhang Y, Curiel TJ, Fang D, Kuzel TM & Zhang B (2014) Host mir155 promotes tumor growth through a myeloid-derived suppressor cell-dependent mechanism. Can Res 75, 519–531.
36. Corzo CA, Condamine T, Lu L, Cotter MJ, Youn JI, Cheng P, Cho HI, Celis E, Quiceno DG, Padhya T et al. (2010) Hif-1a regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med 207, 2439–2453.
37. Yu H, Liu Y, McFarland BC, Deshane JS, Hurst DR, Ponnazhagan S, Benveniste EN & Qin H (2015) SOCS3 deficiency in myeloid cells promotes tumor development: involvement of STAT3 activation and myeloid-derived suppressor cells. Cancer Immunol Res 3, 727–740.
38. Kumar V, Cheng P, Condamine T, Mony S, Languino LR, McCaffrey JC, Hockstein N, Guarino M, Masters G, Penman E et al. (2016) Cd45 phosphatase inhibits stat3 transcription factor activity in myeloid cells and promotes tumor-associated macrophage differentiation. Immunity 44, 303–315.
39. Ji J, Fan H, Li F, Li X, Dong G, Gong W, Song Y, Liu F, Hua C, Tan R et al. (2015) A benzenediamine derivative fc-99 attenuates lupus-like syndrome in mrl/lpr mice related to suppression of pdc activation. Immunol Lett 168, 355–365.